Luis
Pérez de Llano
![Foto de Luis](/img/nophoto.png)
![Foto de Universidad Autónoma de Madrid](/img/noimage_org.png)
Universidad Autónoma de Madrid
Madrid, EspañaPublications in collaboration with researchers from Universidad Autónoma de Madrid (7)
2021
-
EAACI Biologicals Guidelines—Recommendations for severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 14-44
2020
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1043-1057
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1023-1042
-
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1058-1068
2018
-
Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: A network approach
International Journal of COPD, Vol. 13, pp. 591-601
2017
-
Asthma-COPD overlap is not a homogeneous disorder: Further supporting data
Respiratory Research
-
Quality indicators of asthma care derived from the spanish guidelines for asthma management (GEMA 4.0): A multidisciplinary team report
Journal of Investigational Allergology and Clinical Immunology